Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. (Q51316416)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 September 2014

Language	Label	Description	Also known as
English	Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.	scientific article published on 2 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

0 references

Anne-Laure Borel

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

Hans-Ulrich Wittchen

8

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

Steven M. Haffner

14

object named as

S M Haffner

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

author name string

J A Nazare

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

J Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

P Aschner

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

P Barter

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

L Van Gaal

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

C Eng Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

Y Matsuzawa

9

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

T Kadowaki

10

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

R Ross

11

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

C Brulle-Wohlhueter

12

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

N Alméras

13

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

B Balkau

15

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

J P Després

16

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

language of work or name

0 references

publication date

2 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

International Journal of Obesity

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

39

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

495-501

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Abdominal obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Ectopic Fat Storage in the Pancreas, Liver, and Abdominal Fat Depots: Impact on β-Cell Function in Individuals with Impaired Glucose Metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

The impact of liver fat vs visceral fat in determining categories of prediabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Resolution of fatty liver and risk of incident diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Acquired and inherited lipodystrophies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.163

21 January 2018

Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Splanchnic lipolysis in human obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Techniques for the measurement of visceral fat: a practical guide

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/IJO.2014.163

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/25179244

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51316416&oldid=2210809161"